Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination Traditional Chinese Medicine (TCM) therapy developed by Liaoning University of Traditional Chinese Medicine for the treatment of bronchial asthma. The therapy consists of two components: an oral 'warming lung and relieving asthmatic' granule and a topical 'securing origin and warming lung' emplastrum (patch). It is specifically designed for patients presenting with the 'cold' syndrome type of asthma according to TCM theory. The treatment protocol involves oral administration of the granules three times daily and the application of the emplastrum to specific acupuncture points for three hours once daily. This combination was evaluated in a Phase 2 clinical trial to assess its efficacy in managing acute episodes of mild-to-moderate bronchial asthma compared to standard Western treatments like theophylline and budesonide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on warming lung and relieving asthmatic granule + Securing origin and warming lung emplastrum.